Brazil announced that they are suspending the $324 million deal for Bharat Biotech's Covaxin as there are concerns around irregularities in the procurement process.
Brazilian President Bolsonaro is being accused of overlooking possible corruption in a deal to purchase coronavirus vaccines. Brazilian federal prosecutors have opened an investigation into the deal, citing comparatively high prices, quick talks and pending regulatory approvals as red flags for the contract signed in February